SCHEMBL8759491

SCHEMBL8759491

C=CC[N+]1([C@H]2CC3C4CC[C@H]5C[C@H](OC(C)=O)[C@@H](N6CCC(O)CC6)C[C@]5(C)C4CC[C@]3(C)[C@H]2OC(C)=O)CCCC1

nearest known ligand 0.76

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 3/20 0.76
▸ AGTR1 P30556 1/20 0.76
▸ HRH3 Q9Y5N1 1/20 0.69
▸ SLC22A2 O15244 1/20 0.68
▸ SLC47A2 Q86VL8 1/20 0.68
▸ SLC47A1 Q96FL8 1/20 0.68
▸ MEN1 O00255 1/20 0.58
▸ CYP2C9 P11712 1/20 0.58
▸ KMT2A Q03164 1/20 0.58
▸ MTOR P42345 1/20 0.58
▸ CYP2C19 P33261 1/20 0.58
▸ CYP3A4 P08684 1/20 0.58
▸ LMNA P02545 1/20 0.57
▸ RAD52 P43351 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8759496 1.00 KCNH2 (0.76) KCNH2AGTR1HRH3SLC22A2SLC47A2
Bromide SCHEMBL8760418 0.99 KCNH2 (0.75) KCNH2AGTR1HRH3SLC22A2SLC47A2
Bromide SCHEMBL8760594 0.99 KCNH2 (0.75) KCNH2AGTR1HRH3SLC22A2SLC47A2
Bromide SCHEMBL8760605 0.99 KCNH2 (0.75) KCNH2AGTR1HRH3SLC22A2SLC47A2
SCHEMBL13851843 0.95 KCNH2 (0.77) KCNH2AGTR1HRH3SLC22A2SLC47A2
SCHEMBL13890594 0.95 KCNH2 (0.77) KCNH2AGTR1HRH3SLC22A2SLC47A2
Bromide SCHEMBL8761174 0.94 KCNH2 (0.67) KCNH2AGTR1HRH3SLC22A2SLC47A2
SCHEMBL8760682 0.93 KCNH2 (0.86) KCNH2AGTR1HRH3SLC22A2SLC47A2
SCHEMBL8760689 0.93 KCNH2 (0.86) KCNH2AGTR1HRH3SLC22A2SLC47A2
SCHEMBL8760677 0.93 KCNH2 (0.86) KCNH2AGTR1HRH3SLC22A2SLC47A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0608495-B1 Androstane derivatives substituted by a quaternary ammonium group in 16-position, pharmaceutical compositions containing them and process for preparing same MARUISHI PHARMA (JP) 1997-06-04 — — EP claimed
Send feedback